Table 1 Relationship between KDM5B and clinicopathological parameters in 65 PDAC patients.

From: KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma

Variables

All cases

KDM5B expression

P

Low (n = 32)

High (n = 33)

Age (years)

<50

35

15

20

0.267

≥50

30

17

13

 

Gender

Male

 

20

23

0.540

Female

 

12

10

 

Alcohol history

No

 

25

27

0.710

Yes

 

7

6

 

Smoking

No

 

14

9

0.165

Yes

 

18

24

 

Tumor size (cm)

<4

 

20

12

0.049

≥4

 

13

21

 

TNM stage

I–II

 

19

10

0.026

III–IV

 

14

23

 

Lymph node invasion

Absent

 

26

15

0.005

Present

 

7

18

 

Metastasis

No

 

28

16

0.002

Yes

 

5

17

 
Back to article page